A61K 9/2095
Tabletting processes
Official title: {Tabletting processes}
A61K9/2095 (Tabletting processes) appears on 1,839 US grants and 3,345 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,839
- Published applications
- 3,345
- Assignees
- 1,194
- Inventors
- 5,559
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 5 | 0 |
| 1978 | 10 | 0 |
| 1979 | 4 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 10 | 0 |
| 1990 | 6 | 0 |
| 1991 | 11 | 0 |
| 1992 | 2 | 0 |
| 1993 | 7 | 0 |
| 1994 | 9 | 0 |
| 1995 | 16 | 0 |
| 1996 | 23 | 0 |
| 1997 | 27 | 0 |
| 1998 | 33 | 0 |
| 1999 | 31 | 0 |
| 2000 | 34 | 0 |
| 2001 | 32 | 17 |
| 2002 | 26 | 43 |
| 2003 | 30 | 71 |
| 2004 | 24 | 76 |
| 2005 | 9 | 76 |
| 2006 | 14 | 71 |
| 2007 | 17 | 83 |
| 2008 | 19 | 88 |
| 2009 | 13 | 77 |
| 2010 | 36 | 116 |
| 2011 | 31 | 102 |
| 2012 | 43 | 115 |
| 2013 | 69 | 151 |
| 2014 | 102 | 171 |
| 2015 | 83 | 224 |
| 2016 | 105 | 225 |
| 2017 | 112 | 187 |
| 2018 | 101 | 168 |
| 2019 | 82 | 196 |
| 2020 | 104 | 177 |
| 2021 | 112 | 186 |
| 2022 | 84 | 186 |
| 2023 | 80 | 158 |
| 2024 | 102 | 138 |
| 2025 | 99 | 116 |
| 2026 | 60 | 127 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tableting of specific polymer stabilizers6 Oct 2026US 12,751,926 B2BASF SE
- Anticancer compositions29 Sep 2026US 12,746,230 B2Aragon Pharmaceuticals, Inc.
- Delayed release compositions22 Sep 2026US 12,740,951 B2Amneal Complex Products Research LLC
- Pharmaceutical composition comprising enzalutamide8 Sep 2026US 12,728,096 B2Synthon BV
- Multiparticulate pharmaceutical composition of tamsulosin and solifenacin8 Sep 2026US 12,728,106 B2Zim Laboratories Limited
- Drug-polymer amorphous solid dispersions using linear polyacrylic acid polymers8 Oct 2026US 2026/0306410 A1Lubrizol Advanced Materials, Inc.
- Pharmaceutical oral dosage form of q2038 Oct 2026US 2026/0306411 A1Qurient Co., Ltd.
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Additive manufacturing process for producing chemical delivery devices using screening8 Oct 2026US 2026/0307336 A1Genesee Valley Innovations, LLC
- Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide1 Oct 2026US 2026/0294904 A1Hoffmann-La Roche Inc.
Most cited
By later US patents
- System and method for rapidly customizing design, manufacture and/or selection of biomedical devices614US 6,772,026 B2Therics, Inc. · 2004
- Orally administrable opioid formulations having extended duration of effect437US 5,968,551 APurdue Pharma L. P. · 1999
- Extruded orally administrable opioid formulations380US 5,958,452 AEuro-Celtique S. A. · 1999
- Extruded multi-particulates364US 5,965,161 AEuro-Celtique S. A. · 1999
- Method of preparing sustained release pharmaceutical compositions317US 5,849,240 AEuro-Celtique S. A. · 1998